Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
STAR: Our CMT Research Strategy
…more about how the CMT is accelerating research for Demyelinating and Axonal forms of CMT READ MORE: DEMYELINATING CMT ⟶ READ MORE: AXONAL CMT ⟶ Last Updated: November 12, 2024…
2021_Spring_CMTA_Report
CMT2A Research
CMT2A CMT2A is caused by dominant mutations in Mitofusin 2 (MFN2). The STAR team has developed two excellent rat models for CMT2A which are being made available to the research…
NMD Pharma Receives FDA Approval to Initiate Phase II Clinical Trial of NMD670 in CMT Patients
…clinical trial for their investigational drug, NMD670, in patients with Charcot-Marie-Tooth disease (CMT). This trial, named SYNAPSE-CMT, marks a significant milestone in the journey towards finding effective treatments for CMT….
CMTA-STAR Research for Axonal Forms of CMT
…in-depth conversation about STAR please reach out to Jeana Sweeney, Chief Engagement and Gift Officer: jeana@cmtausa.org. Support CMT Research READ MORE ABOUT CMTA-STAR RESEARCH FOR AXONAL TYPES OF CMT CMT…
CMTA Report Fall 2021
2021_Winter_CMTA_Report
Charcot–Marie–Tooth Disease and Breathing Problems
Does CMT cause Breathing Problems? Yes, CMT can cause breathing problems for some. For reasons not understood, not all individuals who have CMT will develop breathing problems. When breathing is…
CMTA Volunteer Spotlight
…laurel@cmtausa.org. CMTActive on Facebook (www.facebook.com/groups/cmtactive/) Benjy Hershorn (CMTActive Moderator and Houston Branch Leader) My name is Benjy Hershorn. Although born and raised in Kansas, I got to Texas “as fast…
X-linked CMT
…CMT1X/X1 is the second most common CMT subtype, accounting for approximately 17% of all CMT cases, second only to CMT1A, which accounts for approximately 60% of all CMT cases. The…